Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abel Tilahun

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|March 11, 2008
Information theory-based surrogate marker evaluation from several randomized clinical trials with binary endpoints, using SASAbel Tilahun, Assam Pryseley, Ariel Alonso, et al.
Clinical Trials (London, England)|November 29, 2007
Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpointsAssam Pryseley, Abel Tilahun, Ariel Alonso, et al.
Lifetime Data Analysis|September 30, 2010
An information-theoretic approach to surrogate-marker evaluation with failure time endpointsAssam Pryseley, Abel Tilahun, Ariel Alonso, et al.
Statistical Methods in Medical Research|July 18, 2009
A unified framework for the evaluation of surrogate endpoints in mental-health clinical trialsGeert Molenberghs, Tomasz Burzykowski, Ariel Alonso, et al.
International Journal of Data Mining and Bioinformatics|July 20, 2013
Comparison of methods for the selection of genomic biomarkersDan Lin, Abel Tilahun, Jose Cortinas Abrahantes, et al.
Journal of Biopharmaceutical Statistics|January 8, 2009
Investigating association between behavior, corticosterone, heart rate, and blood pressure in rats using surrogate marker evaluation methodologyAbel Tilahun, John T Maringwa, Helena Geys, et al.
Journal of Clinical Pharmacology|April 5, 2016
Exposure Matching for Extrapolation of Efficacy in Pediatric Drug DevelopmentYeruk Mulugeta, Jeffrey S Barrett, Robert Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2013
Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapySusan A Fiscus, Susan Cu-Uvin, Abel Tilahun Eshete, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|March 11, 2008
Information theory-based surrogate marker evaluation from several randomized clinical trials with binary endpoints, using SASAbel Tilahun, Assam Pryseley, Ariel Alonso, et al.
Clinical Trials (London, England)|November 29, 2007
Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpointsAssam Pryseley, Abel Tilahun, Ariel Alonso, et al.
Lifetime Data Analysis|September 30, 2010
An information-theoretic approach to surrogate-marker evaluation with failure time endpointsAssam Pryseley, Abel Tilahun, Ariel Alonso, et al.
Statistical Methods in Medical Research|July 18, 2009
A unified framework for the evaluation of surrogate endpoints in mental-health clinical trialsGeert Molenberghs, Tomasz Burzykowski, Ariel Alonso, et al.
International Journal of Data Mining and Bioinformatics|July 20, 2013
Comparison of methods for the selection of genomic biomarkersDan Lin, Abel Tilahun, Jose Cortinas Abrahantes, et al.
Journal of Biopharmaceutical Statistics|January 8, 2009
Investigating association between behavior, corticosterone, heart rate, and blood pressure in rats using surrogate marker evaluation methodologyAbel Tilahun, John T Maringwa, Helena Geys, et al.
Journal of Clinical Pharmacology|April 5, 2016
Exposure Matching for Extrapolation of Efficacy in Pediatric Drug DevelopmentYeruk Mulugeta, Jeffrey S Barrett, Robert Nelson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 28, 2013
Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapySusan A Fiscus, Susan Cu-Uvin, Abel Tilahun Eshete, et al.
Pageof 1